MODELING THE LONG-TERM NEUTRALIZING ANTIBODY PERSISTENCE IN ADULTS AFTER ONE DOSE OF LIVE ATTENUATED JAPANESE ENCEPHALITIS CHIMERIC VIRUS VACCINE

被引：0

作者：

Desai, Kamal ^{[1
]}

Coudeville, Laurent ^{[1
]}

Bailleux, Fabrice ^{[1
]}

机构：

[1] Sanofi Pasteur SA, Lyon, France

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2010年 / 83卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

1050

引用

页码：313 / 314

页数：2

共 50 条

[21] Long-term immunogenicity of single dose of live attenuated hepatitis A vaccine in Indian children
Sheila Bhave
Amita Sapru
Ashish Bavdekar
Vaibhavi Kapatkar
Amey Mane
Indian Pediatrics, 2015, 52 : 687 - 690
[22] Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea
Kim, Dong Soo
Jang, Gwang Cheon
Cha, Sung-Ho
Choi, Soo-Han
Kim, Hwang Min
Kim, Ji Hong
Kang, Jin Han
Kim, Jong-Hyun
Kim, Ki Hwan
Bang, Joon
Naimi, Zulaikha
Bouckenooghe, Alain
Bosch-Castells, Valerie
Houillon, Guy
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (02) : E60 - E64
[23] LONG-TERM PERSISTENCE OF INTRATHECAL VIRUS-SPECIFIC ANTIBODY-RESPONSES AFTER HERPES-SIMPLEX VIRUS ENCEPHALITIS
VANDVIK, B
SKOLDENBERG, B
FORSGREN, M
STIERNSTEDT, G
JEANSSON, S
NORRBY, E
JOURNAL OF NEUROLOGY, 1985, 231 (06) : 307 - 312
[24] JAPANESE ENCEPHALITIS VACCINE - PERSISTENCE OF ANTIBODY UP TO 3 YEARS AFTER A 3-DOSE PRIMARY SERIES
GAMBEL, JM
DEFRAITES, R
HOKE, C
BROWN, A
SANCHEZ, J
KARABATSOS, N
TSAI, T
MESCHIEVITZ, C
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04): : 1074 - 1074
[25] Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
Pittman, PR
Makuch, RS
Mangiafico, JA
Cannon, TL
Gibbs, PH
Peters, CJ
VACCINE, 1996, 14 (04) : 337 - 343
[26] Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
Khan, Siraj Ahmed
Kakati, Sanjeeb
Dutta, Prafulla
Chowdhury, Purvita
Borah, Jani
Topno, Rashmee
Jadhav, Santoshkumar M.
Mohapatra, Pradyumna K.
Mahanta, Jagadish
Gupte, Mohan D.
INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 144 : 886 - 892
[27] Persistence of the neutralizing antibody response one year after a single injection of a new Yellow fever vaccine in adults
Feroldi, Emmanuel
Mulligan, Mark J.
Talaat, Kawsar
Tan, Chen Sabrina
Paolino, Kristopher
Edupuganti, Srilatha
Collins, Matthew H.
George, Sarah L.
Davis, Matthew
Essink, Brandon
Peterson, James
Fried, David
Valero, Natalia Rodriguez
Ramharter, Michael
Launay, Odile
Kantele, Anu
Tantawichien, Terapong
Low, Jenny Guek-Hong
Orlando, Sandrine
Davaux, Pascale
Machabert, Tifany
Dufournet, Marine
Devlin, Louis
Frago, Carina
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
[28] Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis
Guirakhoo, F
Zhang, ZX
Chambers, TJ
Delagrave, S
Arroyo, J
Barrett, ADT
Monath, TP
VIROLOGY, 1999, 257 (02) : 363 - 372
[29] Modeling the Long-term Persistence of Hepatitis A Antibody After a Two-Dose Vaccination Schedule in Argentinean Children
Lopez, Eduardo L.
Marta Contrini, Maria
Mistchenko, Alicia
Kieffer, Alexia
Baggaley, Rebecca F.
Luca Di Tanna, Gian
Desai, Kamal
Rasuli, Anvar
Armoni, Judith
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (04) : 417 - 425
[30] Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
Monath, TP
Guirakhoo, F
Nichols, R
Yoksan, S
Schrader, R
Murphy, C
Blum, P
Woodward, S
McCarthy, K
Mathis, D
Johnson, C
Bedford, P
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (08): : 1213 - 1230

← 1 2 3 4 5 →